Rxintegrity Clinical Consulting LLC is categorized under Business Consultants in Brighton, CO and active since 2010.
Rxintegrity Clinical Consulting LLC was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Sarah C Gilroy at the company’s single location by writing to 7731 East 131st Avenue, Brighton, Colorado CO 80602 or by phoning (303) 704-0297. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rxintegrity Clinical Consulting LLC |
Contact Person: | Sarah C Gilroy |
Address: | 7731 East 131st Avenue, Brighton, Colorado 80602 |
Phone Number: | (303) 704-0297 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Consultants |
SIC Code: | 8748 |
NAICS Code: | 541618 |
Share This Business: |
Rxintegrity Clinical Consulting LLC was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sarah C Gilroy for inquiries that concern Rxintegrity Clinical Consulting LLC by calling the company number (303) 704-0297, as your correspondence is most welcome. Additionally, the physical location of the single location of Rxintegrity Clinical Consulting LLC can be found at the coordinates 39.93489,-104.897838 as well as the street address 7731 East 131st Avenue in Brighton, Colorado 80602.
For its online presence, you may visit Rxintegrity Clinical Consulting LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.